New therapy increases melanin in patients with albinism


A medication used to treat tyrosinemia has been shown to increase melanin production in some people with oculocutaneous albinism type 1B. Watch the healthminute.tv video below for more information.

#Melanin #tyrosinemia

46 views0 comments

Recent Posts

See All

Registration still open for Scleroderma Summit

Tomorrow, May 29, 2021, Chronicle Companies, in collaboration with Mallinckrodt Pharmaceuticals and Scleroderma Canada, is presenting the first Canadian Scleroderma Summit. The meeting will run from 1